Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 2, 2021

Primary Completion Date

March 30, 2026

Study Completion Date

March 30, 2026

Conditions

Squamous Cell Carcinomathe Nasal CavityParanasal Sinuses

Interventions

DRUG

Pembrolizumab

given by IV

DRUG

Docetaxel

given by IV

DRUG

Cisplatin

given by IV

DRUG

Carboplatin

given by IV

Trial Locations (1)

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER